Stem Cells and Cancer (R21)

The summary for the Stem Cells and Cancer (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Stem Cells and Cancer (R21): Purpose. This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), and the National Institute on Aging (NIA), encourages research in all aspects of tumor stem cell biology, including the molecular and biochemical regulation of embryonic and adult stem cell behavior relevant to tumor formation. Tumor stem cells are a rare population of cells that can recapitulate all the cell types represented in the original tumor. Tumor stem cells are capable of self-renewal and asymmetric cell division. These cells are putatively responsible for the transplantability and metastatic properties of tumors. This FOA intends to stimulate efforts on isolation and characterization of tumor stem cells from a large spectrum of tumors. Such studies are important in order to understand the progression of malignant diseases. They may also inspire the development of new therapeutic strategies based on specific targeting of tumor stem cells. In addition, more research is encouraged to understand the genetic and biochemical regulatory mechanisms that control the self-renewal phenotype, asymmetric cell division, and the stem cell microenvironment (or niche ). It is anticipated that the results of such research will ultimately improve the specificity and long-term effectiveness of cancer therapy.
Federal Grant Title: Stem Cells and Cancer (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-08-165
Type of Funding: Grant
CFDA Numbers: 93.39393.394
CFDA Descriptions: Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research
Current Application Deadline: No deadline provided
Original Application Deadline: May 07, 2011
Posted Date: May 02, 2008
Creation Date: May 02, 2008
Archive Date: Dec 05, 2008
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.395 -- Cancer Treatment Research
Applicants Eligible for this Grant
State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Private institutions of higher education Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster